Unlock stock picks and a broker-level newsfeed that powers Wall Street.
NasdaqGS - Nasdaq Real Time Price USD

Sotera Health Company (SHC)

Compare
11.76
-0.02
(-0.13%)
As of 3:47:25 PM EDT. Market Open.
Loading Chart for SHC
  • Previous Close 11.77
  • Open 11.76
  • Bid 10.81 x 200
  • Ask 12.51 x 200
  • Day's Range 11.45 - 11.79
  • 52 Week Range 10.71 - 17.08
  • Volume 442,445
  • Avg. Volume 1,084,449
  • Market Cap (intraday) 3.332B
  • Beta (5Y Monthly) 1.93
  • PE Ratio (TTM) 73.47
  • EPS (TTM) 0.16
  • Earnings Date Apr 30, 2025 - May 5, 2025
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est 15.07

Sotera Health Company provides sterilization, lab testing, and advisory services for the healthcare industry in the United States, Canada, Europe, and internationally. The company operates through three segments: Sterigenics, Nordion, and Nelson Labs. The Sterigenics segment offers outsourced terminal sterilization and irradiation services using gamma irradiation, ethylene oxide processing, and electron beam irradiation technologies for the medical device, pharmaceutical, and food safety and advanced applications markets. The Nordion segment provides Cobalt-60 used in the sterilization and irradiation processes for the medical device, pharmaceutical, food safety, and high-performance materials industries, as well as in the treatment of cancer. It also offers gamma irradiation systems. The Nelson Labs segment provides outsourced microbiological and analytical chemistry testing and advisory services for the medical device and pharmaceutical industries. The company was formerly known as Sotera Health Topco, Inc. and changed its name to Sotera Health Company in October 2020. Sotera Health Company was incorporated in 2015 and is headquartered in Broadview Heights, Ohio.

soterahealth.com

3,000

Full Time Employees

December 31

Fiscal Year Ends

Recent News: SHC

View More

Performance Overview: SHC

Trailing total returns as of 3/31/2025, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .

YTD Return

SHC
14.07%
S&P 500 (^GSPC)
4.53%

1-Year Return

SHC
2.12%
S&P 500 (^GSPC)
6.87%

3-Year Return

SHC
45.73%
S&P 500 (^GSPC)
23.95%

5-Year Return

SHC
56.46%
S&P 500 (^GSPC)
117.26%

Compare To: SHC

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: SHC

View More

Valuation Measures

Annual
As of 3/28/2025
  • Market Cap

    3.34B

  • Enterprise Value

    5.41B

  • Trailing P/E

    73.56

  • Forward P/E

    15.90

  • PEG Ratio (5yr expected)

    1.33

  • Price/Sales (ttm)

    3.05

  • Price/Book (mrq)

    8.24

  • Enterprise Value/Revenue

    4.92

  • Enterprise Value/EBITDA

    12.23

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    4.03%

  • Return on Assets (ttm)

    6.76%

  • Return on Equity (ttm)

    10.46%

  • Revenue (ttm)

    1.1B

  • Net Income Avi to Common (ttm)

    44.34M

  • Diluted EPS (ttm)

    0.16

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    278.05M

  • Total Debt/Equity (mrq)

    580.53%

  • Levered Free Cash Flow (ttm)

    107.18M

Research Analysis: SHC

View More

Company Insights: SHC

Research Reports: SHC

View More

People Also Watch

Waiting for permission
Allow microphone access to enable voice search

Try again.